Skip to main content
. 2015 Nov 16;7(2):1288–1299. doi: 10.18632/oncotarget.6339

Figure 1. MiR-630 is downregulated in breast cancer tissues as well as breast cancer cell lines.

Figure 1

A. Quantitative PCR for comparing the expression levels of miR-630 in 43 paired clinical breast cancer cases. B. Quantitative PCR for detecting miR-630 expression levels in various breast cancer cell lines as indicted. Data represent mean ± SD of three independent experiments. **P < 0.001; **P < 0.001.